H. M. Aytac Et Al. , "COMTVal158Met polymorphism is associated with ecstasy (MDMA)-induced psychotic symptoms in the Turkish population," NEUROSCIENCES , vol.27, no.1, pp.24-30, 2022
Aytac, H. M. Et Al. 2022. COMTVal158Met polymorphism is associated with ecstasy (MDMA)-induced psychotic symptoms in the Turkish population. NEUROSCIENCES , vol.27, no.1 , 24-30.
Aytac, H. M., Oyaci, Y., Aydin, P. C., Pehlivan, M., & Pehlivan, S., (2022). COMTVal158Met polymorphism is associated with ecstasy (MDMA)-induced psychotic symptoms in the Turkish population. NEUROSCIENCES , vol.27, no.1, 24-30.
Aytac, Hasan Et Al. "COMTVal158Met polymorphism is associated with ecstasy (MDMA)-induced psychotic symptoms in the Turkish population," NEUROSCIENCES , vol.27, no.1, 24-30, 2022
Aytac, Hasan M. Et Al. "COMTVal158Met polymorphism is associated with ecstasy (MDMA)-induced psychotic symptoms in the Turkish population." NEUROSCIENCES , vol.27, no.1, pp.24-30, 2022
Aytac, H. M. Et Al. (2022) . "COMTVal158Met polymorphism is associated with ecstasy (MDMA)-induced psychotic symptoms in the Turkish population." NEUROSCIENCES , vol.27, no.1, pp.24-30.
@article{article, author={Hasan Mervan Aytac Et Al. }, title={COMTVal158Met polymorphism is associated with ecstasy (MDMA)-induced psychotic symptoms in the Turkish population}, journal={NEUROSCIENCES}, year=2022, pages={24-30} }